Quest Diagnostics
757 hedge funds and large institutions have $13.4B invested in Quest Diagnostics in 2020 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 240 increasing their positions, 277 reducing their positions, and 77 closing their positions.
19% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 77
1% more funds holding
Funds holding: 748 → 757 (+9)
1% less capital invested
Capital invested by funds: $13.5B → $13.4B (-$127M)
1.34% less ownership
Funds ownership: 88.96% → 87.62% (-1.3%)
13% less repeat investments, than reductions
Existing positions increased: 240 | Existing positions reduced: 277
32% less call options, than puts
Call options by funds: $75.4M | Put options by funds: $110M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$310M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$97.6M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$95.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$87.6M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$85.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$159M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$138M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$94.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$74.7M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$56.5M |
DGX Hedge Fund Activity: Q3 2020 in Review
757 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2020, worth a combined $13.4B — down 0.94% from $13.5B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new DGX positions and 77 closed out — a net gain of 15 holders — while 240 added to existing stakes and 277 trimmed.
The largest buyer was Bank of America, adding an estimated $310M. The largest seller was JP Morgan Chase, cutting an estimated $159M.
- 757 institutional investors held Quest Diagnostics (DGX) as of Q3 2020, up from 748 in Q2 2020.
- Funds reported $13.4B of Quest Diagnostics stock for Q3 2020, down 0.94% quarter-over-quarter.
- 92 funds opened new Quest Diagnostics positions in Q3 2020 and 77 closed out, a net change of +15 holders.
- The largest Quest Diagnostics buyer in Q3 2020 was Bank of America, an estimated $310M added.
- The largest Quest Diagnostics seller in Q3 2020 was JP Morgan Chase, an estimated $159M sold.
Based on aggregated 13F filings for Q3 2020.